BUSINESS BRIEFING / DRUGS
- Share via
Times Wire Reports
Allergan Inc. of Irvine sued Corona-based Watson Pharmaceuticals Inc., alleging infringement of a U.S. patent for Sanctura XR, a prescription medicine used to treat overactive bladder.
Allergan, and business partners Endo Pharmaceuticals Solutions Inc. and Supernus Pharmaceuticals Inc., contend in a federal court complaint that Watson plans to market a generic version of Sanctura before the patent expires in 2025.
Watson did not immediately comment.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
